thyroid cancer and tirzepatide GLP-1RA cancer: New study suggests detection bias, not causation GLP-1 Medications and Thyroid Cancer

Knapp dahinter folgen Jakob Stadler mit dem MAUERBLMCHEN DELUXE und Daniela Rohrsdorfer mit ALLES STEHT KOPF

Originally published in the Off Script newsletter

Emerging Safety Concerns Recent research has identified new safety considerations beyond traditional gastrointestinal effects

Concerns About Drug Interactions: If you are taking other prescription medications, have existing health conditions (e.g., kidney disease, heart disease, history of ulcers), or simply feel uncertain about combining Mounjaro with any other medication, always discuss this with your healthcare provider

Patients often experience decreased appetite, fewer cravings, increased energy, and marked improvements in vital health metrics, including blood pressure and cholesterol levels

Limited human observations corroborate a favorable short-term tolerability profile, usually involving mild, transient reactions such as localized injection-site irritation or temporary gastrointestinal discomfort